Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA
RSS SUMMARY · AGGREGATED FROM CBS NEWS
There's a new safety concern about doctors prescribing one experimental weight loss treatment, retatrutide, that hasn't even been FDA approved yet. Adam Yamaguchi reports.
There's a new safety concern about doctors prescribing one experimental weight loss treatment, retatrutide, that hasn't even been FDA approved yet. Adam Yamaguchi reports.
There's a new safety concern about doctors prescribing one experimental weight loss treatment, retatrutide, that hasn't even been FDA approved yet. Adam Yamaguchi reports.
Continue Reading
The full story continues on CBS News.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CBS NEWS
World News
Iran and Israel cease attacks after weekend hostilities
CBS NEWS·1h ago·3 min read
World News
Federal lawsuit aims to stop UFC fight at White House on Trump’s birthday
CBS NEWS·1h ago·3 min read
World News
Latest details on Trump effort to denaturalize 17 U.S. citizens accused of serious crimes
CBS NEWS·51m ago·3 min read
World News
6/8: CBS Evening News
CBS NEWS·1h ago·3 min read
Related
On this beat
Health
Jim Cramer says he can’t sell Eli Lilly despite its massive run up. Here’s why
CNBC·10h ago·3 min read
Health
Zealand Pharma Shares Slide After Boehringer Study Shows Obesity Shot’s Side Effects
TWSJ·16h ago·3 min read
Health
Weight loss drug maker sinks 25% after new safety data spooks investors
CNBC·17h ago·3 min read
Health
Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success
TWSJ·17h ago·3 min read
